table of content
1 Study Coverage
1.1 Blood-Brain Barrier Transport Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Blood-Brain Barrier Transport Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Carrier-mediated Transport
1.2.3 Receptor-mediated Transport
1.2.4 Absorptive-mediated Transport
1.2.5 Active Efflux Transport
1.2.6 Others
1.3 Market by Application
1.3.1 Global Blood-Brain Barrier Transport Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Alzheimer's Disease
1.3.3 Epilepsy
1.3.4 Parkinson's Disease
1.3.5 Multiple Sclerosis
1.3.6 Hunter's Syndrome
1.3.7 Brain Cancer
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Blood-Brain Barrier Transport Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Blood-Brain Barrier Transport Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Blood-Brain Barrier Transport Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Blood-Brain Barrier Transport Drugs Sales by Region
2.4.1 Global Blood-Brain Barrier Transport Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Blood-Brain Barrier Transport Drugs by Region (2023-2028)
2.5 Global Blood-Brain Barrier Transport Drugs Revenue by Region
2.5.1 Global Blood-Brain Barrier Transport Drugs Revenue by Region (2017-2022)
2.5.2 Global Blood-Brain Barrier Transport Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Blood-Brain Barrier Transport Drugs Sales by Manufacturers
3.1.1 Global Top Blood-Brain Barrier Transport Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Blood-Brain Barrier Transport Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Blood-Brain Barrier Transport Drugs in 2021
3.2 Global Blood-Brain Barrier Transport Drugs Revenue by Manufacturers
3.2.1 Global Blood-Brain Barrier Transport Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Blood-Brain Barrier Transport Drugs Revenue in 2021
3.3 Global Blood-Brain Barrier Transport Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Blood-Brain Barrier Transport Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Blood-Brain Barrier Transport Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Blood-Brain Barrier Transport Drugs Sales by Type
4.1.1 Global Blood-Brain Barrier Transport Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Blood-Brain Barrier Transport Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2017-2028)
4.2 Global Blood-Brain Barrier Transport Drugs Revenue by Type
4.2.1 Global Blood-Brain Barrier Transport Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Blood-Brain Barrier Transport Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Blood-Brain Barrier Transport Drugs Price by Type
4.3.1 Global Blood-Brain Barrier Transport Drugs Price by Type (2017-2022)
4.3.2 Global Blood-Brain Barrier Transport Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Blood-Brain Barrier Transport Drugs Sales by Application
5.1.1 Global Blood-Brain Barrier Transport Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Blood-Brain Barrier Transport Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2017-2028)
5.2 Global Blood-Brain Barrier Transport Drugs Revenue by Application
5.2.1 Global Blood-Brain Barrier Transport Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Blood-Brain Barrier Transport Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Blood-Brain Barrier Transport Drugs Price by Application
5.3.1 Global Blood-Brain Barrier Transport Drugs Price by Application (2017-2022)
5.3.2 Global Blood-Brain Barrier Transport Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Blood-Brain Barrier Transport Drugs Market Size by Type
6.1.1 North America Blood-Brain Barrier Transport Drugs Sales by Type (2017-2028)
6.1.2 North America Blood-Brain Barrier Transport Drugs Revenue by Type (2017-2028)
6.2 North America Blood-Brain Barrier Transport Drugs Market Size by Application
6.2.1 North America Blood-Brain Barrier Transport Drugs Sales by Application (2017-2028)
6.2.2 North America Blood-Brain Barrier Transport Drugs Revenue by Application (2017-2028)
6.3 North America Blood-Brain Barrier Transport Drugs Market Size by Country
6.3.1 North America Blood-Brain Barrier Transport Drugs Sales by Country (2017-2028)
6.3.2 North America Blood-Brain Barrier Transport Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Blood-Brain Barrier Transport Drugs Market Size by Type
7.1.1 Europe Blood-Brain Barrier Transport Drugs Sales by Type (2017-2028)
7.1.2 Europe Blood-Brain Barrier Transport Drugs Revenue by Type (2017-2028)
7.2 Europe Blood-Brain Barrier Transport Drugs Market Size by Application
7.2.1 Europe Blood-Brain Barrier Transport Drugs Sales by Application (2017-2028)
7.2.2 Europe Blood-Brain Barrier Transport Drugs Revenue by Application (2017-2028)
7.3 Europe Blood-Brain Barrier Transport Drugs Market Size by Country
7.3.1 Europe Blood-Brain Barrier Transport Drugs Sales by Country (2017-2028)
7.3.2 Europe Blood-Brain Barrier Transport Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Blood-Brain Barrier Transport Drugs Market Size by Type
8.1.1 Asia Pacific Blood-Brain Barrier Transport Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Blood-Brain Barrier Transport Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Blood-Brain Barrier Transport Drugs Market Size by Application
8.2.1 Asia Pacific Blood-Brain Barrier Transport Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Blood-Brain Barrier Transport Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Blood-Brain Barrier Transport Drugs Market Size by Region
8.3.1 Asia Pacific Blood-Brain Barrier Transport Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Blood-Brain Barrier Transport Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Blood-Brain Barrier Transport Drugs Market Size by Type
9.1.1 Latin America Blood-Brain Barrier Transport Drugs Sales by Type (2017-2028)
9.1.2 Latin America Blood-Brain Barrier Transport Drugs Revenue by Type (2017-2028)
9.2 Latin America Blood-Brain Barrier Transport Drugs Market Size by Application
9.2.1 Latin America Blood-Brain Barrier Transport Drugs Sales by Application (2017-2028)
9.2.2 Latin America Blood-Brain Barrier Transport Drugs Revenue by Application (2017-2028)
9.3 Latin America Blood-Brain Barrier Transport Drugs Market Size by Country
9.3.1 Latin America Blood-Brain Barrier Transport Drugs Sales by Country (2017-2028)
9.3.2 Latin America Blood-Brain Barrier Transport Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Blood-Brain Barrier Transport Drugs Market Size by Type
10.1.1 Middle East and Africa Blood-Brain Barrier Transport Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Blood-Brain Barrier Transport Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Blood-Brain Barrier Transport Drugs Market Size by Application
10.2.1 Middle East and Africa Blood-Brain Barrier Transport Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Blood-Brain Barrier Transport Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Blood-Brain Barrier Transport Drugs Market Size by Country
10.3.1 Middle East and Africa Blood-Brain Barrier Transport Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Blood-Brain Barrier Transport Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Cyclenium
11.1.1 Cyclenium Corporation Information
11.1.2 Cyclenium Overview
11.1.3 Cyclenium Blood-Brain Barrier Transport Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Cyclenium Blood-Brain Barrier Transport Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Cyclenium Recent Developments
11.2 BioAdvance
11.2.1 BioAdvance Corporation Information
11.2.2 BioAdvance Overview
11.2.3 BioAdvance Blood-Brain Barrier Transport Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 BioAdvance Blood-Brain Barrier Transport Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 BioAdvance Recent Developments
11.3 EIP Pharma
11.3.1 EIP Pharma Corporation Information
11.3.2 EIP Pharma Overview
11.3.3 EIP Pharma Blood-Brain Barrier Transport Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 EIP Pharma Blood-Brain Barrier Transport Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 EIP Pharma Recent Developments
11.4 Bioasis
11.4.1 Bioasis Corporation Information
11.4.2 Bioasis Overview
11.4.3 Bioasis Blood-Brain Barrier Transport Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bioasis Blood-Brain Barrier Transport Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bioasis Recent Developments
11.5 Immune Pharmaceuticals
11.5.1 Immune Pharmaceuticals Corporation Information
11.5.2 Immune Pharmaceuticals Overview
11.5.3 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Immune Pharmaceuticals Recent Developments
11.6 AZ Therapies
11.6.1 AZ Therapies Corporation Information
11.6.2 AZ Therapies Overview
11.6.3 AZ Therapies Blood-Brain Barrier Transport Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 AZ Therapies Blood-Brain Barrier Transport Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 AZ Therapies Recent Developments
11.7 Palobiofarma
11.7.1 Palobiofarma Corporation Information
11.7.2 Palobiofarma Overview
11.7.3 Palobiofarma Blood-Brain Barrier Transport Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Palobiofarma Blood-Brain Barrier Transport Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Palobiofarma Recent Developments
11.8 Bach Pharma
11.8.1 Bach Pharma Corporation Information
11.8.2 Bach Pharma Overview
11.8.3 Bach Pharma Blood-Brain Barrier Transport Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bach Pharma Blood-Brain Barrier Transport Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bach Pharma Recent Developments
11.9 BrainsGate
11.9.1 BrainsGate Corporation Information
11.9.2 BrainsGate Overview
11.9.3 BrainsGate Blood-Brain Barrier Transport Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 BrainsGate Blood-Brain Barrier Transport Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 BrainsGate Recent Developments
11.10 CarThera
11.10.1 CarThera Corporation Information
11.10.2 CarThera Overview
11.10.3 CarThera Blood-Brain Barrier Transport Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 CarThera Blood-Brain Barrier Transport Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CarThera Recent Developments
11.11 Dainippon Sumitomo Pharma
11.11.1 Dainippon Sumitomo Pharma Corporation Information
11.11.2 Dainippon Sumitomo Pharma Overview
11.11.3 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Dainippon Sumitomo Pharma Recent Developments
11.12 Fluorinov Pharma
11.12.1 Fluorinov Pharma Corporation Information
11.12.2 Fluorinov Pharma Overview
11.12.3 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Fluorinov Pharma Recent Developments
11.13 Fondazione Telethon
11.13.1 Fondazione Telethon Corporation Information
11.13.2 Fondazione Telethon Overview
11.13.3 Fondazione Telethon Blood-Brain Barrier Transport Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Fondazione Telethon Blood-Brain Barrier Transport Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Fondazione Telethon Recent Developments
11.14 Minoryx
11.14.1 Minoryx Corporation Information
11.14.2 Minoryx Overview
11.14.3 Minoryx Blood-Brain Barrier Transport Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Minoryx Blood-Brain Barrier Transport Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Minoryx Recent Developments
11.15 NewGen Therapeutics
11.15.1 NewGen Therapeutics Corporation Information
11.15.2 NewGen Therapeutics Overview
11.15.3 NewGen Therapeutics Blood-Brain Barrier Transport Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 NewGen Therapeutics Blood-Brain Barrier Transport Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 NewGen Therapeutics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Blood-Brain Barrier Transport Drugs Industry Chain Analysis
12.2 Blood-Brain Barrier Transport Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Blood-Brain Barrier Transport Drugs Production Mode & Process
12.4 Blood-Brain Barrier Transport Drugs Sales and Marketing
12.4.1 Blood-Brain Barrier Transport Drugs Sales Channels
12.4.2 Blood-Brain Barrier Transport Drugs Distributors
12.5 Blood-Brain Barrier Transport Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Blood-Brain Barrier Transport Drugs Industry Trends
13.2 Blood-Brain Barrier Transport Drugs Market Drivers
13.3 Blood-Brain Barrier Transport Drugs Market Challenges
13.4 Blood-Brain Barrier Transport Drugs Market Restraints
14 Key Findings in The Global Blood-Brain Barrier Transport Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
